[PDF][PDF] Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals

…, RS Jadi, D Marrama, AM de Silva, A Frazier… - Cell, 2020 - cell.com
Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development,
interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and calibration of pandemic …

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

…, CE Faliti, A Grifoni, SI Ramirez, S Haupt, A Frazier… - Science, 2021 - science.org
INTRODUCTION Immunological memory is the basis for durable protective immunity after
infections or vaccinations. Duration of immunological memory after severe acute respiratory …

[PDF][PDF] Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity

…, C Kim, SA Rawlings, J Mateus, LPV Tse, A Frazier… - Cell, 2020 - cell.com
Limited knowledge is available on the relationship between antigen-specific immune
responses and COVID-19 disease severity. We completed a combined examination of all three …

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

…, ED Yu, R da Silva Antunes, J Greenbaum, A Frazier… - Science, 2020 - science.org
Many unknowns exist about human immune responses to the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2–reactive CD4 + T cells have been …

[PDF][PDF] Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals

…, P Rubiro, A Sutherland, E Wang, A Frazier… - Cell Reports …, 2021 - cell.com
The emergence of SARS-CoV-2 variants with evidence of antibody escape highlight the
importance of addressing whether the total CD4 + and CD8 + T cell recognition is also affected. …

[PDF][PDF] Humoral and cellular immune memory to four COVID-19 vaccines

…, EA Escarrega, C Kim, B Goodwin, NI Bloom, A Frazier… - Cell, 2022 - cell.com
Multiple COVID-19 vaccines, representing diverse vaccine platforms, successfully protect
against symptomatic COVID-19 cases and deaths. Head-to-head comparisons of T cell, B cell, …

[PDF][PDF] Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases

…, P Rubiro, N Methot, E Phillips, S Mallal, A Frazier… - Cell Reports …, 2021 - cell.com
T cells are involved in control of SARS-CoV-2 infection. To establish the patterns of
immunodominance of different SARS-CoV-2 antigens and precisely measure virus-specific CD4 + …

T cells from patients with Parkinson's disease recognize α-synuclein peptides

…, D Weiskopf, E Phillips, S Mallal, B Peters, A Frazier… - Nature, 2017 - nature.com
Genetic studies have shown the association of Parkinson’s disease with alleles of the major
histocompatibility complex 1 , 2 , 3 . Here we show that a defined set of peptides that are …

[HTML][HTML] α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease

…, R Dhanwani, J Pham, R Kuan, A Frazier… - Nature …, 2020 - nature.com
A diagnosis of motor Parkinson’s disease (PD) is preceded by a prolonged premotor phase
with accumulating neuronal damage. Here we examined the temporal relation between α-…

Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function

…, J Hagen, V Tompkins, AA Frazier… - … and cellular biology, 2005 - Taylor & Francis
The ARF tumor suppressor is a nucleolar protein that activates p53-dependent checkpoints
by binding Mdm2, a p53 antagonist. Despite persuasive evidence that ARF can bind and …